CD47 is extensively overexpressed in cancers and prevents tumor cells from phagocytosis and promotes tumor progression by activating the SIRPα-CD47 axis to avoid immune surveillance [146] (Fig. 5b). This evidence concerns the gene SIRPA and neoplasm.